Login
$INNV
$9.27 -$0.28 (2.93%) Close

$INNV 3 SEC Filings

Filed On Filing
17 Aug 2026 Form 3: Taheri Paul, Chief Medical Officer

Holds 38,765 shares of Common Stock, $0.001 par value

08 Jun 2026 Form 3: Browne Jennifer, President and COO

No securities owned

30 Jan 2026 Form 3: Traynor Sean, Director

No securities owned

30 Jan 2026 Form 3: Mahesh Pavithra, Director

No securities owned

09 Oct 2025 Form 3: Delk Meredith, Chief Administrative Officer

No securities owned

04 Nov 2024 Form 3: Scarbrough Michael Anthony, President and COO

No securities owned

14 Aug 2023 Form 3: Sparks Teresa, Director

No securities owned

11 Jul 2023 Form 3: Adams Benjamin C, CHIEF FINANCIAL OFFICER

No securities owned

03 Apr 2023 Form 3: Fontneau Patricia, Director

No securities owned

23 Mar 2023 Form 3: Bent Christine, CHIEF OPERATIONS OFFICER

No securities owned

17 Aug 2022 Form 3: Feifer Richard, CHIEF MEDICAL OFFICER

No securities owned

05 Jul 2022 Form 3: Carlson James G, Director

No securities owned

03 Dec 2021 Form 3: Blair Patrick T, PRESIDENT

No securities owned

24 Sep 2021 Form 3: Damato Nicole, CHIEF LEGAL OFFICER

Holds 24,880 shares of Common Stock, $0.001 par value

03 Mar 2021 Form 3: Tco Group HOLDINGS, L.p., 10% owner

Holds 116,520,612 shares of Common stock, $0.001 par value

03 Mar 2021 Form 3: Welsh, Carson, Anderson & Stowe XII, L.p., 10% owner and 9 others

Holds 116,520,612 shares of Common stock, $0.001 par value

03 Mar 2021 Form 3: Zoretic Richard C, Director

No securities owned

03 Mar 2021 Form 3: Welch Melissa, CHIEF MEDICAL OFFICER

No securities owned

03 Mar 2021 Form 3: Traynor Sean, Director

No securities owned

03 Mar 2021 Form 3: Tavenner Marilyn B, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support